tripelennamine has been researched along with Bradycardia in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herman, EH | 1 |
| Mhatre, RM | 1 |
| Waravdekar, VS | 1 |
| Lee, IP | 1 |
1 other study available for tripelennamine and Bradycardia
| Article | Year |
|---|---|
Comparison of the cardiovascular actions of NSC-109,724 (ifosfamide) and cyclophosphamide.
Topics: Animals; Antineoplastic Agents; Atropine; Blood Pressure; Bradycardia; Cardiovascular System; Chlorp | 1972 |